Authors:
Velez, C
Aranega, AE
Marchal, JA
Melguizo, C
Prados, JC
Carrillo, E
Aranega, A
Citation: C. Velez et al., Development of chick cardiomyocytes: Modulation of intermediate filaments by basic fibroblast and platelet-derived growth factors, CELLS T ORG, 167(2-3), 2000, pp. 163-170
Authors:
Marchal, JA
Melguizo, C
Prados, J
Aranega, AE
Gomez, JA
Campos, J
Gallo, MA
Espinosa, A
Arena, N
Aranega, A
Citation: Ja. Marchal et al., Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602), JPN J CANC, 91(9), 2000, pp. 934-940
Authors:
Negro, JJ
Bustamante, J
Melguizo, C
Ruiz, JL
Grande, JM
Citation: Jj. Negro et al., Noctural activity of Lesser Kestrels under artificial lighting conditions in Seville, Spain, J RAPT RES, 34(4), 2000, pp. 327-329
Authors:
Aranega, AE
Velez, C
Prados, J
Melguizo, C
Marchal, JA
Arena, N
Alvarez, L
Aranega, A
Citation: Ae. Aranega et al., Modulation of alpha-actin and alpha-actinin proteins in cardiomyocytes by retinoic acid during development, CELLS T ORG, 164(2), 1999, pp. 82-89
Authors:
Prados, J
Melguizo, C
Marchal, JA
Velez, C
Alvarez, L
Aranega, A
Citation: J. Prados et al., Multidrug resistance phenotype in the RMS-GR human rhabdomyosarcoma cell line obtained after polychemotherapy, JPN J CANC, 90(7), 1999, pp. 788-793
Authors:
Marchal, JA
Prados, J
Melguizo, C
Gomez, JA
Campos, J
Gallo, MA
Espinosa, A
Arena, N
Aranega, A
Citation: Ja. Marchal et al., GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells, BR J CANC, 79(5-6), 1999, pp. 807-813
Authors:
Carrillo, E
Marchal, JA
Prados, J
Melguizo, C
Velez, C
Arena, N
Alvarez, L
Serrano, S
Aranega, A
Citation: E. Carrillo et al., Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction, CELL MOL B, 44(8), 1998, pp. 1247-1252